Founder And Ceo
International Bioscience
AeroLeads people directory · profile
Kevin J. Scanlon, Ph.D. Email & Phone Number
Founder and CEO
at
International BioScience
1 work email found
@earthlink.net
1 phone found area 800
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Founder and CEO
Location
Pasadena, California, United States
Who is Kevin J. Scanlon, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kevin J. Scanlon, Ph.D. is listed as Founder and CEO at International BioScience, based in Pasadena, California, United States. AeroLeads shows a work email signal at earthlink.net, phone signal with area code 800, and a matched LinkedIn profile for Kevin J. Scanlon, Ph.D..
Kevin J. Scanlon, Ph.D. previously worked as Chairman Emeritus at Pasadena Angels and Director and Chairman at Pasadena Angels. Kevin J. Scanlon, Ph.D. holds Oncology And Cancer Biology from Yale School Of Medicine.
Company email context
Email format at International BioScience
This section adds company-level context without repeating Kevin J. Scanlon, Ph.D.'s masked contact details.
*@earthlink.net
68% confidence
AeroLeads found 1 current-domain work email signal for Kevin J. Scanlon, Ph.D.. Compare company email patterns before reaching out.
Profile bio
About Kevin J. Scanlon, Ph.D.
Dr. Kevin Scanlon’s career spans roles in academic medicine, senior management in the pharmaceutical industry and biotech companies, as well as an individual investor. Dr. Scanlon was identified by LA Techweek as an individual impacting the Los Angeles business and the technology landscape on a significant scale.During the two years Dr. Scanlon served as the Chairman of Pasadena Angels Investment Group, ~100 investors funded over 50 companies. He has been CEO of four biotechnology companies, including Melanoma Diagnostics, which was sold to Myriad Genetics. At Berlex-Schering AG (Berlin, Germany), he was responsible for the genomic and cancer programs in the US, Europe and Asia.Dr. Scanlon’s notable academic achievements include: Leukemia Society Scholar, Paul Martini Medical Research Prize (Germany), Co-Founder and Co-Editor of the Nature Journal “Cancer Gene Therapy”, President of the International Society of Cell and Gene Therapy, co-authoring 139 peer-reviewed scientific articles and nine medical books. Dr. Scanlon also holds seven issued US Patents.He is also the author of "The Hybrid Entrepreneur" (Amazon.com).Specialties: Life Science, Biotechnology, management and sciences
Listed skills include Start Ups, Entrepreneurship, Biotechnology, Venture Capital, and 46 others.
Current workplace
Kevin J. Scanlon, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles · 22 years
Kevin J. Scanlon, Ph.D. work experience
A career timeline built from the work history available for this profile.
Chairman Emeritus
CurrentThe Pasadena Angel Investment Group has SEC accredited investors for funding novel technology with over 100 accomplished professionals. Our members have a wealth of talent, experience, and a strong business network. The Pasadena Angels was formed in the spring of 2000 by our founder, DuWayne Peterson, based on the core belief that the best way to help.
Jul 2014 - Present
Director And Chairman
Chairman Emeritus of the Pasadena Angel Investment Group. We are SEC accredited investors funding new technology. The Pasadena Angels are over 100 accomplished professionals with a wealth of talent, experience and relationships. Investments total over $50 million in over 120 early stage ventures. Members contribute human and financial capital to build.
2004 - Dec 2014
Founder And Ceo
Current
International Bioscience
The role of International BioScience is to be a catalyst that bridges the worlds of academia, industry and venture capital. These services have been provided to the governments in Ireland, New Zealand and China. The nurturing of creative scientific ideas, coupled with sound business plans will ultimately help transition concepts into commercial reality.
Jun 2004 - Present
Investment Advisor
Sky Venture Group
Sky Ventures Group has launched in Boston, (2015) with plans to provide seed funding to early stage life science and healthcare companies. It holds monthly investor meetings, during which four vetted startups will pitch their concepts to the group. Currently it consists of more than 126 angel investors, 27 corporate investors, family offices and more who.
Jun 2015 - Jul 2022
Professor Of Practice
Entrepreneurial Venture Growth Strategies (a CAP Stone Course): This course focuses on helping Northeastern ventures improve their strategies to achieve external funding. The course teaches frameworks for target markets, customer segmentation, product and service design and validations, team assessments, as well as business and financial models. The.
Jul 2016 - Jun 2022
Entrepreneur In Residence
Northeastern University D'Amore-Mckim
Jul 2015 - Jul 2016
Executive Committee
Sep 2004 - Feb 2014
Co-Founder And Ceo
Melanoma Diagnostics
Melanoma Diagnostics, Inc. is a molecular diagnostics company whose proprietary, patent-pending technology from the University of California San Francisco (UCSF) is unique for evaluating malignant melanoma (skin cancer). This novel technology includes a number of highly validated genetic markers, allowing it to discriminate between normal and melanoma.
Aug 2006 - Aug 2011
Vice President
Berlex/Schering Ag
I was responsible for the Cancer Program in Europe, Asia and the United States for Berlex/Schering AG in Berlin, Germany
Mar 1996 - Jan 2000
3 education records
Kevin J. Scanlon, Ph.D. education
Oncology And Cancer Biology
Yale School Of Medicine
Doctor Of Philosophy (Ph.D.), Molecular Biology
University Of London
Bachelor Of Science (B.Sc.)
Sacred Heart University
FAQ
Frequently asked questions about Kevin J. Scanlon, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Kevin J. Scanlon, Ph.D. work for?
Kevin J. Scanlon, Ph.D. works for International BioScience.
What is Kevin J. Scanlon, Ph.D.'s role at International BioScience?
Kevin J. Scanlon, Ph.D. is listed as Founder and CEO at International BioScience.
What is Kevin J. Scanlon, Ph.D.'s email address?
AeroLeads has found 1 work email signal at @earthlink.net for Kevin J. Scanlon, Ph.D. at International BioScience.
What is Kevin J. Scanlon, Ph.D.'s phone number?
AeroLeads has found 1 phone signal(s) with area code 800 for Kevin J. Scanlon, Ph.D. at International BioScience.
Where is Kevin J. Scanlon, Ph.D. based?
Kevin J. Scanlon, Ph.D. is based in Pasadena, California, United States while working with International BioScience.
What companies has Kevin J. Scanlon, Ph.D. worked for?
Kevin J. Scanlon, Ph.D. has worked for International Bioscience, Pasadena Angels, Sky Venture Group, D’Amore-Mckim School Of Business At Northeastern University, and Northeastern University D'Amore-Mckim.
How can I contact Kevin J. Scanlon, Ph.D.?
You can use AeroLeads to view verified contact signals for Kevin J. Scanlon, Ph.D. at International BioScience, including work email, phone, and LinkedIn data when available.
What schools did Kevin J. Scanlon, Ph.D. attend?
Kevin J. Scanlon, Ph.D. holds Oncology And Cancer Biology from Yale School Of Medicine.
What skills is Kevin J. Scanlon, Ph.D. known for?
Kevin J. Scanlon, Ph.D. is listed with skills including Start Ups, Entrepreneurship, Biotechnology, Venture Capital, Executive Management, Life Sciences, Angel Investing, and Business Strategy.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial